topiramate

SUSPENDED · PHASE3 · Metabolic Syndrome X, Diabetes Mellitus, Type 2

Study was discontinued because of high drop out rate.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.